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Abstract
The World Health Organization (WHO) in May 2016
confirmed an outbreak of the Zika virus on the African
island chain of Cape Verde, linking it to cases of the brain
disease, microcephaly. This finding is of concern because
Zika was first discovered in East Africa in 1947 with no
known link to brain or birth disorders until the WHO
reported findings. The question, therefore, is: if the Zika
virus has been in Africa for 69 years, why wasn’t any
association to microcephaly detected before the recent
WHO findings in Brazil (see below) and Cape Verde? This
study reviews the evidence linking Zika to microcephaly in
view of recent cases of birth defects in Africa, with the aim
of providing vital clues as to why there was no documented
case of such birth defects in Africa, where the Zika virus
originated.
The literature for this review was gathered through internet
searches, including the websites of the European Centre for
Disease Prevention and Control (ECDC), the United States
Centre for Disease Control and Prevention (CDC), the World
Health Organization (WHO) and Public Health England
(PHE).
Materials from these sources were reviewed on the link
between the Zika virus and microcephaly in relation to the
recent cases of birth defects in Africa. Two possible
explanations emerged from the review. The first
explanation suggests that the phenomenon called herd
immunity may have taken place in Africa. The Zika virus
cannot infect the same person twice because it reaches a
stage where there are too few people left to be infected for
transmission to be sustained. The second explanation
suggests that microcephaly linked to birth defects is caused
by other conditions.
In conclusion, the findings of this review opens up the
debate on the connection between the Zika virus and the
birth defect attributed to mosquito-borne microcephaly,
given that there is no documented case of birth defect in
Africa 69 years after the discovery of the Zika virus. Large-
scale research is recommended on the Zika virus and
pregnancy in Africa for better understanding of the ecology
and epidemiology of the virus in the continent.
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Introduction
The Zika virus is a Flavivirus from the family Flaviviridae, which
has emerged as a global mosquito-borne pathogen of growing
public health concern [1]. The Aedes aegypti mosquito was
implicated in a study by Boorman and Porterfield as the main
vector transmitting the Zika virus. This finding was confirmed by
a later experimental study that demonstrated the competence
of the Aedes aegypti mosquito to transmit the Zika virus [2]. The
Aedes aegypti mosquito is one of the two mosquitoes (Aedes
aegypti and Aedes albopictus) that spread the dengue and
chikungunya viruses. The virus is mostly transmitted to
individuals through bites from infected Aedes aegypti
mosquitos. The mosquito becomes infected when it feeds on a
person already infected with the virus; it cannot be caught from
merely coming into contact with the infected person. The
symptoms of an infected person include fever, headache,
myalgia, joint pains, maculopapular rash, eye pain, itching,
arthralgia, muscle pain, and conjunctivitis or “red eye” [1,3].
Serological evidence and virus isolations have demonstrated
widespread distribution of the Zika virus in Africa, the Indian
subcontinent, Southeast Asia, Micronesia and French Polynesia,
and most recently the American continent. For example, the
latest Global Situation Report on Zika by WHO shows that 72
countries and territories have reported evidence of Zika virus
transmission since 2007. The report further shows that since
February 2016, 20 countries or territories have reported
microcephaly potentially associated with Zika virus infection.
Four of the 20 countries reported microcephalic babies born
from mothers in countries with no endemic Zika virus
transmission but who reported recent travel history to Zika-
affected countries [4]. Thus, having considered the evidence
presented at the fourth meeting of the WHO Emergency
Committee on Zika held on 1 September 2016, the Committee
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agreed that, due to continuing geographic expansion and
considerable gaps in understanding of the virus and its
consequences, the Zika virus infection continues to be a Public
Health Emergency of International Concern (WHO, 2016), as
originally notified in February 2016 [5].
In May 2016, WHO tests confirmed 200 cases of Zika virus
with 7,557 suspected cases in the African island chain of Cape
Verde [6]. Cape Verde is an Atlantic archipelago that is about
350 miles (570 km) west of Senegal and which has historic ties to
Brazil [7]. The virus was first isolated in 1947 from a febrile
sentinel rhesus monkey in the Zika forest in Uganda, where it got
its name [1]. The forest at the time was the hub of scientific
research in East Africa and, while carrying out tests on wild
African monkeys in the Zika forest, scientists, whose research
had been funded by the Rockefeller Foundation, unexpectedly
discovered a previously unknown microorganism, which they
later named Zika [8].
According to CDC, Zika showed up in Brazil in 2014 with only
150 cases, which is a very small number for its population,
compared to the outbreak in 2015. The outbreak in Brazil,
beginning in May 2015, was unprecedented and is reported to
have resulted in in more than 1 million cases, with 4,000
suspected cases of microcephaly, and 270 confirmed cases that
health officials believe are linked to the Zika virus [9].
Microcephaly is a condition that makes a baby’s head smaller
than expected when compared to other babies of the same sex
and age. The babies often have smaller brains apparently lacking
in normal development. Other complications of microcephaly
include seizures, hearing loss, vision problems, intellectual
disability such as decreased ability to learn and function in daily
life, developmental delay such as problems with speech or other
developmental milestones, including sitting, standing and
walking. These problems can range from mild to severe, are
often life-long and, in some cases, can be life-threatening [1].
One study shows that the association of Zika virus infection
with pregnancy began during the outbreak of the disease in
north-east Brazil in early 2015. The test carried out by the
Brazilian Ministry of Health identified Zika virus RNA (ribonucleic
acid) in the amniotic fluid of two women whose foetuses had
been found by prenatal ultrasound to have microcephaly [10].
This finding prompted the Brazilian Ministry of Health to report
on its website a possible association of microcephaly with Zika
virus infection during pregnancy. Subsequently, the Pan
American Health Organization (PAHO) reported the
identification of Zika virus RNA by reverse transcription-
polymerase chain reaction (RT-PCR) in in the tests on the two
pregnant women, and the identification of Zika virus RNA from
multiple body tissues, including the brain, of an infant with
microcephaly who died in the immediate neonatal period [11].
The report of these findings prompted both the ECDC and CDC
to publish reports concerning the possible association of
microcephaly with the Zika virus outbreak [12]. The WHO Global
Situation Report on Zika in 2016 reported that Zika virus
infection during pregnancy causes microcephaly [13].
In May 2016, the WHO tests confirmed two hundred cases of
Zika virus with 7,557 suspected cases in the African island chain
of Cape Verde. The Zika virus, linked in Brazil to the birth defect
microcephaly, was first identified in the Ugandan Zika forest in
1947. Until this recent WHO finding, there was no documented
evidence of Zika-associated microcephaly in any part of Africa,
where the virus originated [7]. This once more raises the
question as to what is the connection between Zika virus and
microcephaly. In other words, is mosquito-borne infection
actually the cause of the defects in babies born to Zika-virus-
infected mothers?
Aim and Objective
The aim of this study is to review the evidence linking Zika
virus to the developmental abnormalities that lead to
microcephaly in view of recent cases of birth defects in Africa.
The objective is to provide vital clues as to why there was no
documented case in Africa of such birth defects linked to the
virus during the 69 years since its discovery in East Africa.
Method
The literature for this review was gathered through searches
on Google Scholar and the Google search browser. The European
Centre for Disease Prevention and Control (ECDC), United States
Centre for Disease Control and Prevention (CDC), World Health
Organization (WHO) and Public Health England (PHE) websites
were also searched.
Result
The Zika virus, which has been linked in Brazil to the birth
defect called microcephaly, was first identified in the Ugandan
Zika forest in 1947 [1]. Until the recent WHO finding in Cape
Verde, there was no documented evidence of Zika-associated
microcephaly in any part of Africa, the continent where the virus
originated [7]. This once more raises the question as to what is
the connection between Zika virus and microcephaly. The review
found evidence suggesting that the phenomenon called herd
immunity may have taken place in Africa. The Zika virus cannot
infect the same person twice when it reaches a stage where
there are too few people left to be infected for transmission to
be sustained [13-15]. The review also found evidence suggesting
that microcephaly linked to birth defects is caused by other
conditions [12]. This suggestion re-opens the debate on the
connection between the Zika virus found in pregnant women
and the birth defects attributed to mosquito-borne
microcephaly infections.
Discussion
Until this recent WHO’s finding, there was no documented
evidence of Zika-associated microcephaly in any part of Africa
where the virus originated [7]. The question, therefore, is:
although the Zika virus has been in Africa for 69 years, why was
no association to microcephaly detected before the recent WHO
findings? Two possible explanations emerged from this review:
The first possible explanation is due to a phenomenon called
herd immunity. According to Fine et al. the term herd immunity,
referring to an entire population’s immunity, was used to
Journal of MPE Molecular Pathological Epidemiology
Vol.1 No.1:6
2016
2 This article is available from: http://molecular-pathological-epidemiology.imedpub.com/
describe a naturally occurring phenomenon in the 1930s when it
was observed that, after a large group of children had become
immune to measles infection, new infections decreased in the
short term [13]. In other words, herd immunity becomes a type
of indirect protection from infectious disease, occurring when a
significant percentage of a population has become immune to
an infection, thereby providing a measure of protection for
individuals who are not immune and thus decreasing the
number of new infections [14].
As indicated above, the virus was discovered in the Zika forest
in Uganda 69 years ago. It is common in Africa but it did not
begin spreading widely in the Western Hemisphere until May
2015 when the outbreak occurred in Brazil [16]. Herd immunity
may have been the reason why there was no scientific evidence
linking microcephaly to the Zika virus earlier. The greater the
proportion of individuals in the herd community who are
immune to the virus, the lesser the probability that those who
are not immune will come into contact with an infected
individual [13]. It is not surprising therefore that a new study by
scientists at Imperial College London predicted that “once the
current epidemic is over, herd immunity will lead to a delay of at
least a decade before large epidemics may recur” [15].
The second possible explanation opens up the debate on the
connection between the Zika virus found in pregnant women
and the birth defects attributed to mosquito-borne
microcephaly [17,18]. The WHO Global Situation Report on Zika
virus in 2016 reported that Zika virus infection during pregnancy
is a cause of microcephaly. The conclusion was based on a
systematic review of the literature up to 30 May 2016. However,
the findings, which emerge from a causality framework that
WHO, developed in February 2016 to appraise the strengths and
weaknesses of available evidence, identify gaps in research [4].
The association between viral infections and pregnancy has
long been recognized. For example, one study on viral infections
and pregnancy shows that pregnant women suffer worse
outcomes during viral epidemics and pandemics than the
general population and non-pregnant women. A study explains
that women go through an immunological transformation
during pregnancy. Adverse pregnancy outcomes may result
when the immune system required for promoting and
supporting the pregnancy and growing foetus is compromised
due to infection [19].
In a review of literature, Icheku and Icheku (2016) found no
conclusive evidence that Zika virus infection caused any of the
abnormalities found in the babies with microcephaly. The study
could also not find any conclusive scientific evidence of the full
spectrum of outcomes that might be associated with Zika virus
infection during pregnancy or the factors that might increase
risk of the disease infection to the fetus [1]. However, a
subsequent systematic review panel on Zika virus infection and
neurological disorders found epidemiological studies, which
suggested a marked increase in the risk of brain abnormalities in
fetuses and new-borns when a woman acquires Zika virus
infection during pregnancy [20].
CDC recently reported that the causes of microcephaly in
babies are mostly inconclusive. Some babies have microcephaly
because of other abnormalities. Other causes of microcephaly,
including severe microcephaly, can include exposures during
pregnancy to certain infections such a s rubella, toxoplasmosis
or cytomegalovirus; also to lack of nutrients or not getting
enough food, exposure to harmful substances, such as alcohol,
certain drugs, or toxic chemicals, and interruption of the blood
supply to the baby’s brain during development. Finally, this calls
for large-scale studies to produce conclusive evidence of other
causes of abnormalities in babies born to mothers infected with
Zika virus during pregnancy [12].
Conclusion
The likelihood that herd immunity occurred may explain why
the Zika virus has been in Africa for almost seven decades
without any documented link to microcephaly. Herd immunity
may have provided protection against the Zika virus in Africa
when a significant percentage of the population has become
immune to the disease, thereby providing a measure of
protection for individuals who are not immune and thus
decreasing the number of new infections [14]. In addition, the
absence of large scale studies that produce robust scientific
evidence linking microcephaly to other causes seem to offer
additional clues as to why there had been no known cases of
microcephaly in Africa [12].
Finally, the findings of this review opens up the debate on the
connection between the Zika virus and the birth defect
attributed to mosquito-borne microcephaly, given that until
recently, there is no documented case of birth defect in Africa
where the virus originated. Large-scale research is
recommended on the Zika virus and pregnancy in Africa for
better understanding of the ecology and epidemiology of the
virus in the continent.
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